IM Cannabis (IMCC) Return on Capital Employed (2021 - 2026)
IM Cannabis (IMCC) recorded quarterly Return on Capital Employed of 2108.24% in Q1 2026, up 2480.8% quarter-over-quarter from 88.55% in Q4 2025, and up 342467.0% on a YoY basis from N/an in Q1 2025.
IM Cannabis (IMCC) Return on Capital Employed (2021 - 2026) Analysis & Trends
IM Cannabis' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 2108.24% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 342467.0% year-over-year to 2108.24%; the TTM figure through Mar 2026 stood at 2108.24% (up 342467.0% YoY), while the FY2025 annual figure was 636.73%, down 52834.0% from the prior year.
- Return on Capital Employed was 2108.24% for Q1 2026 at IM Cannabis, up from 88.55% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9515.7% in Q3 2022 to a low of 1316.43% in Q1 2025.
- Historically, Return on Capital Employed has averaged 1355.94% across 5 years, with a median of 46.1% in 2023.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed slumped 819813 bps in 2023, then surged 342467 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 302.53% in 2022, then plunged by 115 bps to 46.1% in 2023, then tumbled by 737 bps to 385.8% in 2024, then soared by 77 bps to 88.55% in 2025, then jumped by 2481 bps to 2108.24% in 2026.
- The last three Return on Capital Employed figures came in at 2108.24% (Q1 2026), 88.55% (Q4 2025), and 406.14% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1.92% |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | 2,108.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,108.24% |
| Dec 31, 2025 | -88.55% |
| Sep 30, 2025 | -406.14% |
| Jun 30, 2025 | -276.23% |
| Mar 31, 2025 | -1,316.43% |
| Dec 31, 2024 | -385.80% |
| Sep 30, 2024 | -453.14% |
| Jun 30, 2024 | -230.73% |
| Mar 31, 2024 | -123.12% |
| Dec 31, 2023 | -46.10% |
| Sep 30, 2023 | 1,317.57% |
| Jun 30, 2023 | 762.55% |
| Mar 31, 2023 | 608.81% |
| Dec 31, 2022 | 302.53% |
| Sep 30, 2022 | 9,515.70% |
| Jun 30, 2022 | 5,487.92% |
| Mar 31, 2022 | 6,273.89% |
| Dec 31, 2021 | 5,542.00% |